NORTH TIDE CAPITAL, LLC
Follow13F filer, CIK 1557543, BOSTON, MA
NORTH TIDE CAPITAL, LLC reported $924,260,000 across 15 holdings for the quarter ended 2016-03-31, in a 13F-HR filed 2016-05-16. Its ten largest share positions make up 89.96% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-16-065427
- Period
- 2016-03-31
- Reported value
- $924M
- Holdings
- 15
- Top 10 weight
- 89.96%
- New
- 2
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CYHadded | +3,500,000 | $64.8M |
| SUPERVALU INCadded | +6,000,000 | $34.6M |
| BKDadded | +2,000,000 | $31.8M |
| THCnew | +500,000 | $14.5M |
| HALYARD HEALTH INCnew | +500,000 | $14.4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AMEDISYS INCreduced | -1,500,000 | -$72.5M |
| Mallinckrodt Plcexited | -750,000 | -$56M |
| MYLAN NVreduced | -750,000 | -$34.8M |
| ORTHOFIX INTL N Vreduced | -500,000 | -$20.8M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2016
Share positions as resolved from 13F-HR 0001140361-16-065427, largest first. % of portfolio is the value over $924,261,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SEMSELECT MED HLDGS CORP | 13,100,000 | $155M | 16.74% | 0 | Timeline | ||
| SUPERVALU INCSUPERVALU INC | 24,000,000 | $138M | 14.96% | +6,000,000 | |||
| CYHCOMMUNITY HEALTH SYS INC NEW | 6,500,000 | $120M | 13.02% | +3,500,000 | Timeline | ||
| KINDRED HEALTHCARE INCKINDRED HEALTHCARE INC | 8,250,000 | $102M | 11.02% | +750,000 | |||
| BKDBROOKDALE SR LIVING INC | 5,500,000 | $87.3M | 9.45% | +2,000,000 | Timeline | ||
| MYLAN NVMYLAN NV | 1,250,000 | $57.9M | 6.27% | -750,000 | |||
| TEVATEVA PHARMACEUTICAL INDS LTD | 1,000,000 | $53.5M | 5.79% | 0 | Timeline | ||
| ALMOST FAMILY INCALMOST FAMILY INC | 1,250,000 | $46.5M | 5.04% | 0 | |||
| HEALTHWAYS INCHEALTHWAYS INC | 4,500,000 | $45.4M | 4.91% | 0 | |||
| SYNERON MEDICAL LTDSYNERON MEDICAL LTD | 3,500,000 | $25.6M | 2.77% | 0 | |||
| AMEDISYS INCAMEDISYS INC | 500,000 | $24.2M | 2.62% | -1,500,000 | |||
| ORTHOFIX INTL N VORTHOFIX INTL N V | 500,000 | $20.8M | 2.25% | -500,000 | |||
| VIVUS INCVIVUS INC | 13,585,300 | $19M | 2.06% | +1,085,300 | |||
| THCTENET HEALTHCARE CORP | 500,000 | $14.5M | 1.57% | new | Timeline | ||
| HALYARD HEALTH INCHALYARD HEALTH INC | 500,000 | $14.4M | 1.55% | new |
Sold out in Q1 2016
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| Mallinckrodt PlcMallinckrodt Plc | 750,000 | $56M | shares |
How Q1 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001140361-16-065427 | base | 2016-05-16 | acceptance time not in the bulk data set |